Back to Journals » ImmunoTargets and Therapy » Volume 7

ImmunoTargets and Therapy

ISSN: 2253-1556


Archive: Volume 7, 2018

Immunological targets for cancer therapy: new recognition

Shurin MR

ImmunoTargets and Therapy 2018, 7:83-85

Published Date: 21 November 2018

Alteration of gene expression profile in CD3+ T-cells after downregulating MALT1

Wang X, Lu S, Xiao Y, Xu L, Zhou L, Hu JY, Li B, Zeng C, Li Y

ImmunoTargets and Therapy 2018, 7:77-81

Published Date: 20 November 2018

Review of checkpoint immunotherapy for the management of non-small cell lung cancer

Raju S, Joseph R, Sehgal S

ImmunoTargets and Therapy 2018, 7:63-75

Published Date: 31 July 2018

Multiple effects of CD40–CD40L axis in immunity against infection and cancer

Ara A, Ahmed KA, Xiang J

ImmunoTargets and Therapy 2018, 7:55-61

Published Date: 28 June 2018

Melanoma treatment in review

Domingues B, Lopes JM, Soares P, Pópulo H

ImmunoTargets and Therapy 2018, 7:35-49

Published Date: 7 June 2018

Oncogenes in immune cells as potential therapeutic targets

Zakiryanova GK, Wheeler S, Shurin MR

ImmunoTargets and Therapy 2018, 7:21-28

Published Date: 11 April 2018

Immunotherapy in Merkel cell carcinoma: role of Avelumab

Palla AR, Doll D

ImmunoTargets and Therapy 2018, 7:15-19

Published Date: 2 March 2018

Antibody targeting of phosphatidylserine for the detection and immunotherapy of cancer

Belzile O, Huang X, Gong J, Carlson J, Schroit AJ, Brekken RA, Freimark BD

ImmunoTargets and Therapy 2018, 7:1-14

Published Date: 23 January 2018